Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply
Resilience and Lilly expand strategic partnership first established in 2023 Investment will significantly increase U.S. production of Lilly’s...
BLOG
Read on
Resilience Announces Relocation of West Coast Headquarters to Ohio and Expansion of Sterile Manufacturing Capabilities
BLUE ASH, Ohio, June 18, 2026 – Resilience, along with Ohio Governor Mike DeWine, JobsOhio, the City of Blue Ash, and REDI Cincinnati, today...
From Complexity to Clarity - Sharpening Focus for Long-Term Performance in a More Demanding CDMO Era
Published by Drug Development & Delivery Resilience has spent the past year reshaping its business with a clear objective: sharpen focus, strengthen...
Executive Interview: Advancing Therapies That Transform Lives
Drug Development & Delivery recently interviewed Susan Billings, Ph.D., Chief Commercial Officer of Resilience, to discuss pressing issues in the...
Meet the Team: Viral Vector Development & Manufacturing
Meet Kyle Anderson, Ph.D., Director of Manufacturing Science and Technology (MSAT) at Resilience RTP, North Carolina & Xiaotong Fu, Ph.D., Head of...
How Resilience Is Bringing Forward Thinking to Disrupt the Biomanufacturing Landscape to Increase Access to Medicines
While many biopharmaceutical companies are built to fulfill a need, Resilience was built to serve innovation. Founded during the COVID-19 pandemic in...
